Financial statements Pharmanea
Balance sheet data of PHARMANEA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 90 283,20 | 117 397,07 | 132 700,17 | 177 878,75 | 218 804,00 | 274 918,34 |
| A. Fixed assets | 4 723,86 | 3 729,30 | 2 734,74 | 1 740,18 | 745,62 | 0,00 |
| B. Current assets | 85 559,34 | 113 667,77 | 129 965,43 | 176 138,57 | 218 058,38 | 274 918,34 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | - | - | - | - |
| Total liabilities | 90 283,20 | 117 397,07 | 132 700,17 | 177 878,75 | 218 804,00 | 274 918,34 |
| A. Equity | 35 937,07 | -56 682,28 | -76 599,19 | -92 225,74 | -39 306,41 | 6 110,34 |
| B. Liabilities and provisions for liabilities | 54 346,13 | 174 079,35 | 209 299,36 | 270 104,49 | 258 110,41 | 268 808,00 |
| I. Long-term liabilities | 0,00 | - | - | - | - | - |
| II. Short-term liabilities | 54 346,13 | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.